Lauren Merendino - 18 Jul 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Chief Commercial Officer
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
18 Jul 2022
Net transactions value
-$21,930
Form type
4
Filing time
20 Jul 2022, 16:37:07 UTC
Previous filing
21 Apr 2022
Next filing
20 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale $21,930 -1,704 -0.97% $12.87 173,249 18 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.